Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Flavio Caprioli

Showing results (121-130 of 176) with videos related to

Pageof 18
Sort By:
Immunity|December 4, 2014
ATP-gated ionotropic P2X7 receptor controls follicular T helper cell numbers in Peyer's patches to promote host-microbiota mutualismMichele Proietti, Vanessa Cornacchione, Tanja Rezzonico Jost, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 31, 2014
IL-21 is a central memory T cell-associated cytokine that inhibits the generation of pathogenic Th1/17 effector cellsIlko Kastirr, Stefano Maglie, Moira Paroni, et al.
Journal of Crohn'S & Colitis|April 27, 2018
Pathogenicity of In Vivo Generated Intestinal Th17 Lymphocytes is IFNγ DependentGiulia Nizzoli, Claudia Burrello, Fulvia Milena Cribiù, et al.
Inflammatory Bowel Diseases|September 11, 2015
PNPLA3 148M Carriers with Inflammatory Bowel Diseases Have Higher Susceptibility to Hepatic Steatosis and Higher Liver EnzymesRosellina Margherita Mancina, Rocco Spagnuolo, Marta Milano, et al.
Journal of Cachexia, Sarcopenia and Muscle|October 2, 2025
Immunoproteasome Inhibition Positively Impacts the Gut-Muscle Axis in Duchenne Muscular DystrophyAndrea Farini, Francesco Strati, Monica Molinaro, et al.
Inflammatory Bowel Diseases|July 14, 2021
COVID-19 Vaccination Willingness and Hesitancy in Patients With Inflammatory Bowel Diseases: Analysis of Determinants in a National Survey of the Italian IBD Patients' AssociationAndrea Costantino, Daniele Noviello, Francesco Simone Conforti, et al.
Journal of Crohn'S & Colitis|November 19, 2020
Seroprevalence of SARS-CoV2 in IBD Patients Treated with Biologic TherapyRoberto Berte', Stefano Mazza, Marta Rachele Stefanucci, et al.
Inflammatory Bowel Diseases|April 2, 2019
Comparative Efficacy of Vedolizumab and Adalimumab in Ulcerative Colitis Patients Previously Treated With InfliximabAgnese Favale, Sara Onali, Flavio Caprioli, et al.
Autoimmunity Reviews|April 29, 2026
Dynamic profiling in inflammatory Bowel disease: A manifesto for personalized careGiuseppe Privitera, Mariangela Allocca, Luca Antonioli, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 10, 2023
Transition care in patients with IBD: The pediatric and the adult gastroenterologist's perspective. Results from a national surveyFabiana Castiglione, Luca Scarallo, Olga Maria Nardone, et al.
Pageof 18

Showing results (121-130 of 176) with videos related to

Sort By:
Pageof 18
Immunity|December 4, 2014
ATP-gated ionotropic P2X7 receptor controls follicular T helper cell numbers in Peyer's patches to promote host-microbiota mutualismMichele Proietti, Vanessa Cornacchione, Tanja Rezzonico Jost, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 31, 2014
IL-21 is a central memory T cell-associated cytokine that inhibits the generation of pathogenic Th1/17 effector cellsIlko Kastirr, Stefano Maglie, Moira Paroni, et al.
Journal of Crohn'S & Colitis|April 27, 2018
Pathogenicity of In Vivo Generated Intestinal Th17 Lymphocytes is IFNγ DependentGiulia Nizzoli, Claudia Burrello, Fulvia Milena Cribiù, et al.
Inflammatory Bowel Diseases|September 11, 2015
PNPLA3 148M Carriers with Inflammatory Bowel Diseases Have Higher Susceptibility to Hepatic Steatosis and Higher Liver EnzymesRosellina Margherita Mancina, Rocco Spagnuolo, Marta Milano, et al.
Journal of Cachexia, Sarcopenia and Muscle|October 2, 2025
Immunoproteasome Inhibition Positively Impacts the Gut-Muscle Axis in Duchenne Muscular DystrophyAndrea Farini, Francesco Strati, Monica Molinaro, et al.
Inflammatory Bowel Diseases|July 14, 2021
COVID-19 Vaccination Willingness and Hesitancy in Patients With Inflammatory Bowel Diseases: Analysis of Determinants in a National Survey of the Italian IBD Patients' AssociationAndrea Costantino, Daniele Noviello, Francesco Simone Conforti, et al.
Journal of Crohn'S & Colitis|November 19, 2020
Seroprevalence of SARS-CoV2 in IBD Patients Treated with Biologic TherapyRoberto Berte', Stefano Mazza, Marta Rachele Stefanucci, et al.
Inflammatory Bowel Diseases|April 2, 2019
Comparative Efficacy of Vedolizumab and Adalimumab in Ulcerative Colitis Patients Previously Treated With InfliximabAgnese Favale, Sara Onali, Flavio Caprioli, et al.
Autoimmunity Reviews|April 29, 2026
Dynamic profiling in inflammatory Bowel disease: A manifesto for personalized careGiuseppe Privitera, Mariangela Allocca, Luca Antonioli, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 10, 2023
Transition care in patients with IBD: The pediatric and the adult gastroenterologist's perspective. Results from a national surveyFabiana Castiglione, Luca Scarallo, Olga Maria Nardone, et al.
Pageof 18